International Biotechnology Trust’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

International Biotechnology Trust’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-24,000	Closed	-$367K	–	64
2018 Q4	$367K	Buy	+24,000	New	+$494K	0.23%	45
2018 Q3	–	Sell	-24,000	Closed	-$906K	–	57
2018 Q2	$906K	Hold	24,000	–	–	0.35%	49
2018 Q1	$784K	Hold	24,000	–	–	0.31%	59
2017 Q4	$1.17M	Hold	24,000	–	–	0.41%	50
2017 Q3	$1.3M	Sell	24,000 -52,000	-68%	-$3.05M	0.5%	41
2017 Q2	$4.27M	Buy	76,000 +50,000	+192%	+$2M	1.62%	19
2017 Q1	$1.02M	Buy	+26,000	New	+$828K	0.39%	49

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

International Biotechnology Trust's PTLA Position: Q1 2019 in Review

International Biotechnology Trust sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2019, closing a stake of 24,000 shares — an estimated $367K sold.

International Biotechnology Trust first reported a position in PTLA in Q1 2017 and held it in 7 quarters. The position peaked at $4.27M in Q2 2017. 209 funds tracked by Wall St. Rank hold PTLA as of Q1 2019.

International Biotechnology Trust reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
International Biotechnology Trust sold 24,000 Portola Pharmaceuticals, Inc. shares in Q1 2019, an estimated $367K.
International Biotechnology Trust first reported a position in Portola Pharmaceuticals, Inc. in Q1 2017 and held it in 7 quarters.
International Biotechnology Trust's Portola Pharmaceuticals, Inc. position peaked at $4.27M in Q2 2017.
209 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2019.

Based on International Biotechnology Trust's 13F filing for Q1 2019, filed 14 May 2019.